急性冠脉综合征和经皮冠状动脉介入术后:贫血、出血、输血研究进展  

Anemia,Hemorrhage,and Transfusion in Acute Coronary Syndromes and Percutaneous Coronary Intervention

作　　者：程晋芳[1] 杨天伦[1] 

机构地区：[1]中南大学湘雅医院心内科,湖南长沙410008

出　　处：《心血管病学进展》2010年第6期840-842,共3页Advances in Cardiovascular Diseases

摘　　要：急性冠脉综合征(ACS)是心内科常见急症。药物涂层支架及抗血小板药物的不断更新,使ACS病人经皮冠状动脉介入治疗术后缺血事件的发生率大幅度降低,但与治疗相伴随的出血并发症却逐渐增加,成为ACS治疗中发生率最高的并发症之一。出血引起贫血或基线水平贫血的ACS病人构成了冠心病又一高危人群。输血作为贫血和急性出血治疗手段并不能明显改善患者预后,但已被纳入评价该类病人危险分层的指标。Acute coronary syndrome（ACS） is a common cardiovascular disease for which percutaneous coronary intervention（PCI） became the first-choice therapy for most patients.The adoption of PCI,and other newer antithrombotic and antiplatelet regimens,significantly improved patient ischemic outcomes.However,the possibility of a hemorrhage then becomes a complication for the ACS patient undergoing treatment.Other risk factors for ACS patient survival are anemia and decreasing hemoglobin.Transfusion alone is not a sufficient therapeutic method to treat ACS patients,however,it is a marker for increased risk in this patient population.

关 键 词：急性冠脉综合征 经皮冠状动脉介入治疗术 贫血 出血 输血 

分 类 号：R541.41[医药卫生—心血管疾病]